Skip Navigation



Carcinogenesis Advance Access published online on August 19, 2004

Carcinogenesis, doi:10.1093/carcin/bgh251
© 2004 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
25/12/2407    most recent
bgh251v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by van der Logt, E. M. J.
Right arrow Articles by Peters, W. H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Logt, E. M. J.
Right arrow Articles by Peters, W. H. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received April 19, 2004
Revised June 30, 2004
Accepted July 25, 2004

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk

E. M. J. van der Logt 1, S. M. Bergevoet 1, H. M. J. Roelofs 1, Z. van Hooijdonk 1, R. H. M. te Morsche 1, T. Wobbes 2, J. B. de Kok 3, F. M. Nagengast 1, W. H. M. Peters 1*

1 Department of Gastroenterology, University Medical Centre St Radboud, Nijmegen, The Netherlands
2 Department of Surgery, University Medical Centre St Radboud, Nijmegen, The Netherlands
3 Department of Clinical Chemistry, University Medical Centre St Radboud, Nijmegen, The Netherlands

* To whom correspondence should be addressed. E-mail: w.peters{at}mdl.umcn.nl.


   Abstract

Colorectal cancer (CRC) is one of the most common malignancies in the Western world showing an increasing incidence, and has been associated with genetic and lifestyle factors. Individual susceptibility to CRC may be partly due to variations in detoxification capacity in the gastrointestinal tract. Genetic polymorphisms in detoxification enzymes may result in variations in detoxification activities, which subsequently might influence the levels of toxic/carcinogenic compounds, and this may influence the risk for CRC. To determine whether genetic polymorphisms in detoxification enzymes predispose to the development of CRC, 371 patients with sporadic CRC and 415 healthy controls were genotyped for polymorphisms in the important detoxification enzymes UDP-glucuronosyltransferase UGT1A1, UGT1A6, UGT1A7 and UGT1A8, and glutathione S-transferase GSTA1, GSTM1, GSTP1 and GSTT1. Patients and controls were all of Caucasian origin. DNA was isolated from either blood or tissue and tested by polymerase chain reaction followed by restriction fragment length polymorphism analyses. Logistic regression analyses showed significant ageand gender-adjusted risks for CRC associated with variant genotypes of UGT1A6 (OR 1.5, 95% CI 1.03-2.3) and UGT1A7 (OR 2.4, 95% CI 1.3-4.6), whereas no associations were found between CRC and the other polymorphic genes as mentioned above. In conclusion, these data suggest that the presence of variant UGT1A6 and UGT1A7 genotypes with expected reduced enzyme activities, might enhance susceptibility to CRC.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.